 | | PRD_001006 | | Name: | [Aba5,7,12,14]BTD-2 | | Formula: | C82 H156 N36 O18 S2 | | Definition date: | 2013-02-27 | | Last modified: | 2013-06-03 |
|
 | | PRD_001009 | | Name: | [Aba3,5,7,12,14,16]BTD-2 | | Formula: | C84 H162 N36 O18 | | Definition date: | 2013-02-27 | | Last modified: | 2013-06-03 |
|
 | | PRD_001054 | | Name: | peptide inhibitor, syc59 | | Formula: | C24 H38 N4 O6 | | Definition date: | 2013-02-20 | | Last modified: | 2013-06-03 |
|
 | | PRD_001061 | | Name: | peptide inhibitor, syc 10 | | Formula: | C30 H42 N4 O6 | | Definition date: | 2013-02-20 | | Last modified: | 2013-06-03 |
|
 | | PRD_001062 | | Name: | peptide inhibitor, syc8 | | Formula: | C28 H38 N4 O6 | | Definition date: | 2013-02-20 | | Last modified: | 2013-06-03 |
|
 | | PRD_000776 | | Name: | Lyngbyastatin 7 | | Formula: | C48 H66 N8 O12 | | Definition date: | 2013-02-06 | | Last modified: | 2013-06-03 |
|
 | | PRD_000830 | | Name: | N-[(2S)-3-[(S)-(4-bromophenyl)(hydroxy)phosphoryl]-2-{[3-(3'-chlorobiphenyl-4-yl)-1,2-oxazol-5-yl]methyl}propanoyl]-L-alpha-glutamyl-L-alpha-glutamine | | Formula: | C35 H35 Br Cl N4 O10 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
 | | PRD_000865 | | Name: | N-[(2S)-3-[(R)-(4-bromophenyl)(hydroxy)phosphoryl]-2-{[3-(3'-chlorobiphenyl-4-yl)-1,2-oxazol-5-yl]methyl}propanoyl]-L-a
lanyl-L-alaninamide | | Formula: | C31 H31 Br Cl N4 O6 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
 | | PRD_000866 | | Name: | N-{(2S)-3-[(S)-(4-bromophenyl)(hydroxy)phosphoryl]-2-[(3-phenyl-1,2-oxazol-5-yl)methyl]propanoyl}-L-alpha-glutamyl-L-al
pha-glutamine | | Formula: | C29 H32 Br N4 O10 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
 | | PRD_000868 | | Name: | N-{(2S)-3-[(R)-(4-bromophenyl)(hydroxy)phosphoryl]-2-[(3-phenyl-1,2-oxazol-5-yl)methyl]propanoyl}-L-alanyl-L-alaninamid
e | | Formula: | C25 H28 Br N4 O6 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
 | | PRD_001016 | | Name: | Glidobactin | | Formula: | C27 H46 N4 O6 | | Definition date: | 2013-02-06 | | Last modified: | 2023-11-03 |
|
 | | PRD_001018 | | Name: | Cepafungin I | | Formula: | C28 H48 N4 O6 | | Definition date: | 2013-02-06 | | Last modified: | 2023-11-03 |
|
 | | PRD_000979 | | Name: | N3Phe-Leu-Leu-Phe(4-NH2CH2)-methyl vinyl sulfone, bound form | | Formula: | C33 H49 N7 O5 S | | Definition date: | 2013-01-30 | | Last modified: | 2013-01-30 |
|
 | | PRD_000992 | | Name: | HMB-Val-Ser-Phe(4-NH2CH2)-methyl vinyl sulfone, bound form | | Formula: | C28 H40 N4 O7 S | | Definition date: | 2013-01-30 | | Last modified: | 2013-01-30 |
|
 | | PRD_000993 | | Name: | N3Phe-Phe(4-NH2CH2)-Leu-Phe(4-NH2CH2)-methyl vinyl sulfone, bound form | | Formula: | C37 H50 N8 O5 S | | Definition date: | 2013-01-30 | | Last modified: | 2013-01-30 |
|
 | | PRD_000908 | | Name: | N-(3-carboxypropanoyl)-L-valyl-N-[(1S)-2-phenyl-1-phosphonoethyl]-L-prolinamide | | Formula: | C22 H32 N3 O8 P | | Definition date: | 2013-01-23 | | Last modified: | 2013-01-23 |
|
 | | PRD_000898 | | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S,16S,19S,22S)-16-(3-AMINO-3-OXOPROPYL)-2,13-DIBENZYL-12,22-DIHYDROXY-3,5,17-TRIMETHYL-8-(2-METHYLPROPYL)-4,7,10,15,18,21-HEXAOXO-19-(PROPAN-2-YL)-3,6,9,14,17,20-HEXAAZATRICOSAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE (NON-PREFERRED NAME) | | Formula: | C50 H74 N8 O12 | | Definition date: | 2013-01-16 | | Last modified: | 2013-06-03 |
|
 | | PRD_000899 | | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S)-2,13-DIBENZYL-12-HYDROXY-3,5-DIMETHYL-8-(2-METHYLPROPYL)-15-(3-[(METHYLSULFONYL)AMINO]-5-{[(1R)-1-PHENYLETHYL]CARBAMOYL}PHENYL)-4,7,10,15-TETRAOXO-3,6,9,14-TETRAAZAPENTADECAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE | | Formula: | C53 H67 N7 O11 S | | Definition date: | 2013-01-16 | | Last modified: | 2013-06-03 |
|
 | | PRD_000901 | | Name: | thiomuracin A derivative | | Formula: | C53 H54 N13 O9 S6 | | Definition date: | 2012-12-26 | | Last modified: | 2023-11-03 |
|
 | | PRD_000958 | | Name: | tert-butyl {(2S)-1-[(1R,2S,5S)-2-{[(2S,3R)-4-amino-1-cyclopropyl-3-hydroxy-4-oxobutan-2-yl]carbamoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hex-3-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate | | Formula: | C26 H44 N4 O6 | | Definition date: | 2012-12-26 | | Last modified: | 2012-12-26 |
|
 | | PRD_000001 | | Name: | Actinomycin D | | Formula: | C62 H86 N12 O16 | | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXZ) | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000006 | | Name: | 8-Fluoro-Actinomycin D | | Formula: | C62 H85 F N12 O16 | | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXF)
THE CHROMOPHORE PXF IS A MODIFIED PXZ WITH
C-F REPLACING C-H IN POSITION 8 OF THE
PHENOXAZONE RING. | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000007 | | Name: | Actinomycin X2 | | Formula: | C62 H84 N12 O17 | | Description: | ACTINOMYCIN X2 CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXZ) | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000009 | | Name: | Actinomycin Z3 | | Formula: | C62 H83 Cl N12 O18 | | Description: | ACTINOMYCIN Z3 CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXZ) | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000010 | | Name: | 7-AminoActinomycin | | Formula: | C62 H87 N13 O16 | | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PX1)
THE CHROMOPHORE PX1 IS A MODIFIED PXZ
WITH C-NH2 REPLACING C-H IN POSITION 7 OF THE
PHENOXAZONE RING. | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
